The Cancer Imaging Archive (TCIA) Public Access

Space shortcuts

Child pages
  • A dataset of histopathological whole slide images for classification of Treatment effectiveness to ovarian cancer (Ovarian Bevacizumab Response)
Title: A dataset of histopathological whole slide images for classification of Treatment effectiveness to ovarian cancer (Ovarian Bevacizumab Response)  
Author: natasha honomichl Mar 24, 2021
Last Changed by: Tracy Nolan Nov 29, 2023
Tiny Link: (useful for email) https://wiki.cancerimagingarchive.net/x/dYf7B
Export As: Word · PDF  
Hierarchy
Parent Page
    Page: Collections
Labels
There are no labels assigned to this page.
Page Permissions
Page restrictions:
  • Only users in group cip-staff can edit this page. (set by natasha honomichl at Mar 24, 2021 12:08)
  • Only users in group tcia-team can edit this page. (set by natasha honomichl at Mar 24, 2021 12:08)
  • Only nhonomichl can edit this page. (set by natasha honomichl at Mar 24, 2021 12:08)
  • Only tracyn can edit this page. (set by Tracy Nolan at Jul 19, 2021 14:10)
Recent Changes
Time Editor  
Nov 29, 2023 15:44 Tracy Nolan View Changes
Nov 08, 2023 14:39 Tracy Nolan View Changes
Nov 08, 2023 14:36 Tracy Nolan View Changes
Nov 06, 2023 10:33 natasha honomichl View Changes
updating pathology download link for version 1 with new URL following Faspex update
Sep 22, 2023 21:37 Tracy Nolan  
Outgoing Links
External Links (9)
    https://gcc02.safelinks.protection.outlook.com/?url=https%3…
    https://doi.org/10.1016/j.compmedimag.2022.102093
    https://doi.org/10.1007/s10278-013-9622-7
    www.cancerimagingarchive.net/support/
    https://www.ibm.com/aspera/connect/
    mailto:help@cancerimagingarchive.net
    https://doi.org/10.7937/TCIA.985G-EY35
    https://urldefense.proofpoint.com/v2/url?u=https-3A__doi.or…
    https://www.cancerimagingarchive.net/publications/
The Cancer Imaging Archive (TCIA) Public Access (1)     Page: A dataset of histopathological whole slide images for classification of Treatment effectiveness to ovarian cancer (Ovarian Bevacizumab Response)